Latest On Convatec Group Plc (CNVVY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-08-23 06:03 EST | Dividend | A dividend of $0.07 has been announced on Jul 30, 2024. It will be paid Oct 21, 2024 with an ex-dividend date of Aug 23, 2024. | Neutral |  |
| 2024-04-25 06:03 EST | Dividend | A dividend of $0.18 has been announced on Mar 6, 2024. It will be paid Jun 7, 2024 with an ex-dividend date of Apr 25, 2024. | Neutral | |
| 2023-08-17 06:03 EST | Dividend | A dividend of $0.07 has been announced on Aug 2, 2023. It will be paid Oct 13, 2023 with an ex-dividend date of Aug 17, 2023. | Neutral | |
| 2023-04-10 06:02 EST | Dividend | A dividend of $0.17 has been announced on Mar 9, 2023. It will be paid Jun 9, 2023 with an ex-dividend date of Apr 10, 2023. | Neutral | |
| 2022-08-25 06:03 EST | Dividend | A dividend of $0.07 has been announced on Aug 4, 2022. It will be paid Oct 21, 2022 with an ex-dividend date of Aug 25, 2022. | Neutral | |
| 2022-08-06 19:06 EST | News | ConvaTec Group Plc (CNVVF) CEO Karim Bitar on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-03-31 06:05 EST | Dividend | A dividend of $0.17 has been announced on Mar 17, 2022. It will be paid Jun 3, 2022 with an ex-dividend date of Mar 31, 2022. | Neutral | |
| 2022-03-09 00:16 EST | News | ConvaTec Group Plc (CNVVF) CEO Karim Bitar on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-09-02 06:07 EST | Dividend | A dividend of $0.07 has been announced on Aug 2, 2021. It will be paid Oct 28, 2021 with an ex-dividend date of Sep 2, 2021. | Neutral | |
| 2021-04-05 06:06 EST | Dividend | A dividend of $0.11 has been announced on Nov 30, -0001. It will be paid May 27, 2021 with an ex-dividend date of Apr 5, 2021. | Neutral | |
| 2021-03-31 13:21 EST | News | ConvaTec nabs Ostomy Products contract from Vizient | N/A | |
| 2021-03-07 00:39 EST | News | Convatec Group Plc (CNVVF) CEO Karim Bitar on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-06 13:28 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-05 11:12 EST | News | Convatec Group Plc 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2020-11-26 23:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 02:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-03 06:03 EST | Dividend | A dividend of $0.07 has been announced on Aug 6, 2020. It will be paid Oct 29, 2020 with an ex-dividend date of Sep 3, 2020. | Neutral | |
| 2020-08-14 11:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-12 05:27 EST | News | ConvaTec Group PLC (CNVVF) CEO Karim Bitar on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-08 10:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-07 08:25 EST | News | Convatec Group Plc 2020 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-08-06 15:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 17:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 03:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 08:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-03 10:59 EST | News | Convatec Group's (CNVVF) CEO Karim Bitar on Q1 2020 Results - Earnings Call Transcript | N/A | |
| 2020-05-02 22:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 22:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 23:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-02 06:08 EST | Dividend | A dividend of $0.16 has been announced on Mar 3, 2020. It will be paid May 29, 2020 with an ex-dividend date of Apr 2, 2020. | Neutral | |
| 2020-03-25 22:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-01 01:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-29 03:50 EST | News | Convatec Group Plc (CNVVF) CEO Karim Bitar on Full Year 2019 Results - Earnings Call Transcript | N/A | |
About Convatec Group Plc (CNVVY):
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group Plc was incorporated in 2016 and is headquartered in Reading, the United Kingdom.
General
- Name Convatec Group Plc
- Symbol CNVVY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 9,600
- Fiscal Year EndDecember
- Web URLhttp://www.convatecgroup.com
View More
Valuation
- Trailing PE 48.93
- Forward PE 19.92
- Price/Sales (Trailing 12 Mt.) 2.83
- Price/Book (Most Recent Quarter) 3.2
- Enterprise Value Revenue 3.35
- Enterprise Value EBITDA 15
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 6%
- Operating Margin 12%
- Return on Assets 4%
- Return on Equity 7%
- Revenue 1.89 billion
- Earnings Per Share $0.22
- Revenue Per Share $3.8
- Gross Profit 1.02 billion
- Quarterly Earnings Growth 5.1%
View More
Highlights
- Market Capitalization 5.46 billion
- EBITDA 390.8 million
- PEG Ratio 1.1
- Book Value Per Share $3.34
View More
Share Statistics
- Shares Outstanding 501.09 million
- Shares Float 393.25 million
- % Held by Insiders <1%
View More
Technicals
- Beta 0.73
- 52 Week High $11.24
- 52 Week Low $7.36
- 50 Day Moving Average 10.79
- 200 Day Moving Average 10.37
View More
Dividends
- Forward Annual Dividend Rate $0.18
- Forward Annual Dividend Yield 1.66%
- Payout Ratio 812%
- Dividend Date 2021-05-27
- ExDividend Date 2021-04-05
- Dividend Per Share $0.06
- Dividend Yield 0%
View More
Convatec Group Plc (CNVVY) Dividend Calendar:
CNVVY's last dividend payment was made to shareholders on May 27, 2021.
Convatec Group Plc pays out 812% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Convatec Group Plc (CNVVY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-12-31 | $N/A | $0.01 | $0.00 | |
| 2020-06-30 | 2020-09-30 | $N/A | $0.01 | $0.00 | |
| 2020-03-31 | 2020-06-30 | $N/A | $0.01 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $469.15 million | $0.01 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $469.15 million | -$0.01 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $444.45 million | -$0.01 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $444.45 million | $0.01 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $455.4 million | $0.01 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $455.4 million | $0.03 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $349.35 million | $0.03 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $356.73 million | $0.03 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $466.65 million | $0.03 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $466.65 million | $0.03 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $415.65 million | $0.03 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $415.65 million | $0.01 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $429.7 million | $0.01 | $0.00 | |
| 2016-09-30 | 2016-12-31 | $429.7 million | -$0.04 | $0.00 | |
| 2016-06-30 | 2016-09-30 | -$0.04 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | -$0.32 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | -$0.36 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $0.81 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | -$0.30 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | -$0.69 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | -$0.66 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | -$1.25 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | -$0.21 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | -$0.47 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | -$0.63 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | -$0.58 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | -$0.22 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | -$0.33 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | -$0.43 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.14 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | -$0.45 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | -$0.43 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | -$0.69 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | -$0.50 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.25 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | -$1.19 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | -$1.10 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | -$2.70 | $0.00 |
Convatec Group Plc (CNVVY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | 15.05 million |
| Income Before Tax | N/A | N/A | N/A | N/A | -21.2 million |
| Selling General Administrative | N/A | N/A | N/A | N/A | 185.6 million |
| Gross Profit | N/A | N/A | N/A | N/A | 248.2 million |
| Ebit | N/A | N/A | N/A | N/A | -5.2 million |
| Operating Income | N/A | N/A | N/A | N/A | -5.2 million |
| Income Tax Expense | 19.9 million | 19.9 million | 11.2 million | 11.2 million | -3.85 million |
| Total Revenue | N/A | N/A | N/A | N/A | 469.15 million |
| Cost of Revenue | N/A | N/A | N/A | N/A | 220.95 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -16 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | -17.35 million |
| Net Income Applicable to Common Shares | 26.7 million | 26.7 million | 29.55 million | 29.55 million | -17.35 million |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | 200000 | 200000 | 21.15 million | 21.15 million | 750000 |
| Total Cash Flow from Investing Activities | -18.35 million | -18.35 million | -20.85 million | -20.85 million | -15.55 million |
| Net Borrowings | -5.15 million | -5.15 million | -58.6 million | -58.6 million | -20.7 million |
| Total Cash Flow from Financial Activities | N/A | N/A | -76 million | -76 million | -50.25 million |
| Change to Operating Activities | -150000 | -150000 | -20.7 million | -20.7 million | 21.35 million |
| Change in Cash | N/A | N/A | 4.9 million | 4.9 million | 30.2 million |
| Total Cash from Operating Activities | 77.55 million | 77.55 million | 103.9 million | 103.9 million | 97 million |
| Depreciation | N/A | N/A | 55.45 million | 55.45 million | 49.45 million |
| Other Cash Flow from Investing Activities | N/A | N/A | 200000 | 200000 | 200000 |
| Change to Inventory | N/A | N/A | 4.7 million | 4.7 million | 5.5 million |
| Change to Account Receivables | N/A | N/A | 2.35 million | 2.35 million | -9.3 million |
| Other Cash Flow from Financing Activities | N/A | N/A | -10.4 million | -10.4 million | N/A |
| Change to Net Income | 9.95 million | 9.95 million | 61.85 million | 61.85 million | 3.45 million |
| Capital Expenditures | N/A | N/A | 15.25 million | 15.25 million | 15.45 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 2.1 billion | N/A | N/A | N/A | 2.05 billion |
| Total Stockholder Equity | 1.67 billion | N/A | N/A | N/A | 1.56 billion |
| Other Current Liabilities | 72.7 million | 72.7 million | N/A | N/A | 48.8 million |
| Total Assets | 3.77 billion | N/A | N/A | N/A | 3.61 billion |
| Common Stock | 245.5 million | 245.5 million | 245 million | 245 million | 242.9 million |
| Other Current Assets | 6.4 million | 6.4 million | N/A | N/A | N/A |
| Retained Earnings | -845.3 million | -845.3 million | -864.4 million | -864.4 million | -847.7 million |
| Other Liabilities | 132.8 million | 132.8 million | 145.9 million | 145.9 million | 136.1 million |
| Other Assets | 60.4 million | 60.4 million | 72.9 million | 72.9 million | 68.5 million |
| Cash | 565.4 million | N/A | N/A | N/A | 385.8 million |
| Total Current Liabilities | 513.2 million | 513.2 million | N/A | N/A | 397.3 million |
| Other Stockholder Equity | 2.16 billion | 2.16 billion | 2.05 billion | 2.05 billion | 2.11 billion |
| Property, Plant & Equipment | 438 million | 438 million | 402.1 million | 402.1 million | 406.1 million |
| Total Current Assets | 1.18 billion | 1.18 billion | N/A | N/A | 968.3 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -418.9 million | -418.9 million | -538.2 million | -538.2 million | -605.9 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | 1.37 billion | N/A | N/A | N/A | 1.45 billion |
| Inventory | 297.1 million | 297.1 million | N/A | N/A | 281.8 million |
| Accounts Payable | 334.1 million | 334.1 million | N/A | N/A | 289.3 million |
Convatec Group Plc (CNVVY) Chart:
Convatec Group Plc (CNVVY) News:
Below you will find a list of latest news for Convatec Group Plc (CNVVY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Convatec Group Plc (CNVVY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Convatec Group Plc (CNVVY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2017-04-19 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1694271/000101915517000112/0001019155-17-000112-index.htm |
| 2017-01-12 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1694271/000119380517000033/0001193805-17-000033-index.htm |
| 2017-03-08 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1694271/000119380517000422/0001193805-17-000422-index.htm |
| 2017-07-25 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1694271/000119380517001315/0001193805-17-001315-index.htm |
| 2017-09-29 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1694271/000119380517002644/0001193805-17-002644-index.htm |
| 2019-11-25 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1694271/000119380519001848/0001193805-19-001848-index.htm |